Yan-Fang Xing1, Jia-Rong Cai2, Jun-Jian Qin1, Wen-Ying Zhou3, Can-Ming Li4, Xing Li5. 1. Department of Nephrology, The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, China. 2. Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 3. Department of Central Laboratory, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 4. Department of Nephrology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. 5. Department of Medical Oncology and Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Abstract
Background: The specific mechanism of cardiovascular and cerebrovascular vasculopathy in the context of end-stage renal disease has not been elucidated. In the present study, we investigated the clinical impact of myeloid-derived suppressor cells (MDSCs) on hemodialysis patients and their mechanism of action. Methods: MDSCs were tested among 104 patients undergoing hemodialysis and their association with overall survival (OS) and cardiovascular and cerebrovascular events was determined. Results: Hemodialysis patients presented a significantly higher level of monocytic MDSCs (M-MDSCs) compared to healthy controls. M-MDSC were tested 3 months after first testing among 103 hemodialysis patients, with one patient not retested due to early death. The repeated results of M-MDSC levels were consistent with the initial results. Patients with persistent high level of M-MDSCs presented decreased OS, as well as increased stroke and acute heart failure events. As illustrated by multivariate Cox regression, M-MDSC was an independent predictor for OS and stroke events of hemodialysis patients. T cell proliferations were significantly abrogated by hemodialysis-related M-MDSCs in a dose-dependent manner. Besides, M-MDSCs presented higher levels of CXCR4 and VLA-4 compared to monocytes, which indicated their enhanced capability to be recruited to atherosclerotic lesions. The expression of arginase I and activity of arginase was also significantly raised in hemodialysis-related M-MDSCs. Human coronary arterial endothelial cells (HCAECs) presented increased capability to migration by coculture with M-MDSCs, compared with monocyte group. Arginase inhibitor and L-arginine abrogated the immune suppressive function and induction of HCAECs migration of hemodialysis related M-MDSC. Plasma IFN-γ, TNF-α and IL-6 were elevated in hemodialysis patients compared with healthy control. M-MDSC level was positively related to IL-6 level among hemodialysis patients. The plasma of hemodialysis patients induced M-MDSCs significantly compared with plasma from health donors. Besides, IL-6 neutralizing antibody significantly abrogated the induction. Neutralizing antibody of IFN-γ and TNF-α partially decreased the generation of arginase of the induced M-MDSC. Conclusions: M-MDSCs were elevated in ESRD patients under hemodialysis, and they exhibited a strong association with the risk of cardiovascular and cerebrovascular diseases. Hemodialysis related M-MDSC presented enhanced recruitment to atherosclerotic lesions, promoted the migration of endothelial cells through exhaustion of local L-arginine.
Background: The specific mechanism of cardiovascular and cerebrovascular vasculopathy in the context of end-stage renal disease has not been elucidated. In the present study, we investigated the clinical impact of myeloid-derived suppressor cells (MDSCs) on hemodialysis patients and their mechanism of action. Methods: MDSCs were tested among 104 patients undergoing hemodialysis and their association with overall survival (OS) and cardiovascular and cerebrovascular events was determined. Results: Hemodialysis patients presented a significantly higher level of monocytic MDSCs (M-MDSCs) compared to healthy controls. M-MDSC were tested 3 months after first testing among 103 hemodialysis patients, with one patient not retested due to early death. The repeated results of M-MDSC levels were consistent with the initial results. Patients with persistent high level of M-MDSCs presented decreased OS, as well as increased stroke and acute heart failure events. As illustrated by multivariate Cox regression, M-MDSC was an independent predictor for OS and stroke events of hemodialysis patients. T cell proliferations were significantly abrogated by hemodialysis-related M-MDSCs in a dose-dependent manner. Besides, M-MDSCs presented higher levels of CXCR4 and VLA-4 compared to monocytes, which indicated their enhanced capability to be recruited to atherosclerotic lesions. The expression of arginase I and activity of arginase was also significantly raised in hemodialysis-related M-MDSCs. Human coronary arterial endothelial cells (HCAECs) presented increased capability to migration by coculture with M-MDSCs, compared with monocyte group. Arginase inhibitor and L-arginine abrogated the immune suppressive function and induction of HCAECs migration of hemodialysis related M-MDSC. Plasma IFN-γ, TNF-α and IL-6 were elevated in hemodialysis patients compared with healthy control. M-MDSC level was positively related to IL-6 level among hemodialysis patients. The plasma of hemodialysis patients induced M-MDSCs significantly compared with plasma from health donors. Besides, IL-6 neutralizing antibody significantly abrogated the induction. Neutralizing antibody of IFN-γ and TNF-α partially decreased the generation of arginase of the induced M-MDSC. Conclusions: M-MDSCs were elevated in ESRDpatients under hemodialysis, and they exhibited a strong association with the risk of cardiovascular and cerebrovascular diseases. Hemodialysis related M-MDSC presented enhanced recruitment to atherosclerotic lesions, promoted the migration of endothelial cells through exhaustion of local L-arginine.
Authors: Mehmet Kanbay; Yalcin Solak; Hilmi Umut Unal; Yasemin Gulcan Kurt; Mahmut Gok; Hakki Cetinkaya; Murat Karaman; Yusuf Oguz; Tayfun Eyileten; Abdulgaffar Vural; Adrian Covic; David Goldsmith; Osman Turak; Mahmut Ilker Yilmaz Journal: Int Urol Nephrol Date: 2014-05-23 Impact factor: 2.370
Authors: Adam M Zawada; Lisa H Fell; Kathrin Untersteller; Sarah Seiler; Kyrill S Rogacev; Danilo Fliser; Loems Ziegler-Heitbrock; Gunnar H Heine Journal: Cytometry A Date: 2015-06-09 Impact factor: 4.355
Authors: Huina Zhang; Jian Liu; Dan Qu; Li Wang; Chi Ming Wong; Chi-Wai Lau; Yuhong Huang; Yi Fan Wang; Huihui Huang; Yin Xia; Li Xiang; Zongwei Cai; Pingsheng Liu; Yongxiang Wei; Xiaoqiang Yao; Ronald Ching Wan Ma; Yu Huang Journal: Proc Natl Acad Sci U S A Date: 2018-07-02 Impact factor: 11.205
Authors: Solene M Evrard; Laura Lecce; Katherine C Michelis; Aya Nomura-Kitabayashi; Gaurav Pandey; K-Raman Purushothaman; Valentina d'Escamard; Jennifer R Li; Lahouaria Hadri; Kenji Fujitani; Pedro R Moreno; Ludovic Benard; Pauline Rimmele; Ariella Cohain; Brigham Mecham; Gwendalyn J Randolph; Elizabeth G Nabel; Roger Hajjar; Valentin Fuster; Manfred Boehm; Jason C Kovacic Journal: Nat Commun Date: 2016-06-24 Impact factor: 14.919